Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ i2)rDek3]T
k]ptk^
£¨ÃâÒßѧרҵºÍרҵ»ù´¡£© \SA5@
.W
dkLc"$(O
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© W>bhSKV%
%* vYX0W"
1.Co-stimulators (or co-stimulating molecules) ZRsDn
8/Z
JkI
2.NK-kB V0c*M>V
v^H
DR 3I
3.Immunoglobulin superfamily T{{J'
_s5L
H.v`JNs(
4.antigen-presenting cell (APC) UN_lK<utF
M!;H3*
5.death domain rV[#4,} PF
J<>z}L{
6.CCR and CXCR *{)[:;
B`T|M$Ug
7.Lectin (or mitogen) `jvIcu5c
MS_&;2
8.Clusters of differentiation, CD) B#B$w_z
0A9x9l9Wd
9.B7 family OzX\s=
w`c9_V
10.Cytotoxic T lymphocyte, CTL) D7 [n^WtL
|\XjA4j
11.IL-15 and IL-15 receptor (IL-15R) &z
1A-O
v
-]+XTsL
12.MHC restriction ;6e#W!
i>7f9D7
13.Affinity-chromatography yodJGGAzk
;=5V)1~i1;
14.Cyctosprin A, CsA 8rGW G
N#bWMZ"
15.Antibody-dependent cell-mediated cytotoxicity, ADCC) 7I&7YhFI
)>\J~{
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© \Y
Cj/tG8
I{_St8
1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 LJc
w->
p27A#Uu2}
2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØϵ¡£ m{JiF-=u
e%R+IH5i
3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌص㡣 prlB9,3|C
Q= + Frsk
Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£© 9x;/q7
^W_}Gd<-#Y
ÃâÒßѧרҵ£º FT[oM<M\Xd
V*=cNj
1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£ { )'D<:T
Jtd@8fVi
Ïû»¯ÄÚ¿Æ£º _xl#1>G^J
,^26.p$
2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ i>ORCOOU
,RCjfXa
ѪҺ²¡Ñ§×¨Òµ£º }sPY+ZjV
R>/M>*C
3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎΪÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿